Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Prostaglandins Other Lipid Mediat. 2014 Sep 26;0:62–68. doi: 10.1016/j.prostaglandins.2014.09.002

Figure 4.

Figure 4

Effect of 24 hr treatment with PGE2, the EP4 agonist, and the EP1/EP3 agonist sulprostone on total PAI-1 in NVF as measured by ELISA. The values on the lower x-axis represent molar concentrations. Statistical significance: * p < 0.05. *** p < 0.005 versus vehicle treatment, n = 9.